superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2019-12-31
- Valid until
- 2020-12-31
- Published
- 2020-02-12
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 9,139,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen operating income: 9,674,000,000 United States dollar", as of 2019-12-31 (until 2020-12-31). Claim clm_10BA888AB580, https://asof.is/claim/clm_10BA888AB580, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815420000017/0000318154-20-000017-index.htm.
APA
AsOf. (2019). Amgen operating income: 9,674,000,000 United States dollar (as of 2019-12-31 (until 2020-12-31)) [Record clm_10BA888AB580]. Retrieved November 8, 2026, from https://asof.is/claim/clm_10BA888AB580 (source: https://www.sec.gov/Archives/edgar/data/318154/000031815420000017/0000318154-20-000017-index.htm)
BibTeX
@misc{asof_clm_10BA888AB580,
author = {AsOf},
title = {Amgen operating income: 9,674,000,000 United States dollar},
year = {2019},
howpublished = {\url{https://asof.is/claim/clm_10BA888AB580}},
note = {Claim clm\_10BA888AB580, as of 2019-12-31 (until 2020-12-31); source: https://www.sec.gov/Archives/edgar/data/318154/000031815420000017/0000318154-20-000017-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_10BA888AB580.md/v1/claims/clm_10BA888AB580submit a correction